Intravitreal Aflibercept Injection for Radiation Retinopathy Trial
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Amy C Schefler, MD
Retina Consultants Houston
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Retina Consultants of Houston/texas Medical Center
Houston, Texas, United States
- Retina Consultants of Houston
Katy, Texas, United States
- Retina Consultants of Houston/the Woodlands
The Woodlands, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Jul 2017
- Primary completion
- 31 Oct 2021
- Completion
- 31 Oct 2021
- Last update posted
- 8 Dec 2020
- Registered enrollment
- 40
- Registry id
- NCT03085784
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.